RFC1 and neuropathy: Our study is similar to that of Curro et al.18 in the proportion of RFC1-positive patients who had a non-length-dependent neuropathy—we found 80% compared with their 70% (26% all absent and 46% ‘non-length-dependent’), and this was significantly more common than in gene-negative patients (P = 0.005).